System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Mathias W Pletz is an expert in Infectiology at Jena University Hospital (Germany). As of October 2026, ScienceLeadR ranks Mathias W Pletz in the top 1% of experts worldwide for Community-Acquired Pneumonia and Pneumonia. Mathias W Pletz has authored 678 publications, the most recent in 2026, and is an investigator in 15 clinical trials, 2 of them ongoing. SLR score: 2,075 (community average: 125). How the SLR is computed.

LeadR Profile

Mathias W Pletz Jena University Hospital Germany
2 075 ScienceLeadR Reputation 2075

Unlock

Register Login
Network Map

Infectiology

Subspecialties: Pulmonology - Critical Care - Public Health

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2001 - 2026
Source: PubMed

Jena University Hospital

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 678

Citations

Citations: 19 126 1st author: 67 Last author: 118 Unique author: 15

Main journals

Infection 46
Pneumologie 34
Dtsch Med Wochenschr 23
Clin Microbiol Infect 16
PLoS One 16

Best Journals

JAMA 6
Intensive Care Med 5
N Engl J Med 4

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Cardioprotective Vaccination Effects: Association Between Vaccination Knowledge, Risk Perception, and Vaccination Intention in Older Patients with Pre-Existing Conditions.
PMID 42931430 — pneumococcal infections, vaccines, cardiovascular diseases, preexisting condition coverage, perception, respiratory tract infections, vaccination, influenza, human, patient education as topic, infections		Vaccines (Basel)20260
Epidemiology, risk factors and clinical outcome of community-acquired pneumonia in severely immunosuppressed patients: a comprehensive analysis from the multinational, prospective CAPNETZ Cohort.
PMID 42865940 — epidemiology, pharmaceutical preparations, antineoplastic agents, pneumonia, risk factors, therapeutics, steroids, transplantation, prognosis, community-acquired pneumonia		ERJ Open Res20261
Healthcare pathways and outpatient management prior to community-acquired sepsis hospitalization in Germany, 2016-2019.
PMID 42862469 — hospitalization, emergencies, prescriptions, sepsis, ambulatory care, outpatients, infections		Infection20260
Pneumococcal serotype distribution and diagnostic yield of serotype-specific urinary antigen detection in adults with CAP in Switzerland, 2016-2021: a prospective cohort study.
PMID 42773420 — pneumococcal infections, vaccines, cohort studies, pneumonia, communicable diseases		BMC Infect Dis20260
A consensus-based guideline for personalized bacteriophage therapy.
PMID 42768217 — phage therapy, molecular biology, bacteriophages, research, therapeutics, bacteria		Nat Med Top journal20260

Clinical Studies 15

Sources: ClinicalTrials, EU CTIS

Synthesis

Study Chair: 1

By phase:

N/A 11
Phase 2 2
Phase 3 2

By status:

Completed 7
Recruiting 6
Unknown 2

By type:

Observational 9
Interventional 6

By Monocentric/Multicentric:

monocentric 4
multicentric2to4 0
multicentric5to9 0
multicentricup10 11

Main Topics

Cohort/Consortium Investigators 11

Ongoing Clinical Trials

2 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Acyclovir in Ventilated Patients With Pneumonia and HSV 1 in BAL
NCT06134492 — healthcare-associated pneumonia, herpes simplex, acyclovir, pneumonia, viral, bronchoalveolar lavage, administration, intravenous, stress, physiological, pneumonia, ventilator-associated, respiratory tract infections, simplexvirus, herpesviridae, herpesvirus 1, human, pneumonia, viruses, physicians, immune system, body weight, therapeutics, ventilation, infections, community-acquired pneumonia		Phase 3Recruiting2024
Optimization of Sepsis Therapy Based on Patient specific Digital Precision Diagnostics
NCT04571801 — bacteremia, high-throughput nucleotide sequencing, toxemia, mortality, blood, shock, septic, sepsis, work, radar, diagnosis, therapeutics, blood culture, communicable diseases, infections		N/ARecruiting2022

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS